Revised: 23 May 2013


Release of information relating to the approval process for the meningococcal B vaccine (MeNZB) application

Relevant extract from Minutes of the Medicines Assessment Advisory Committee Meeting 8th March 2005 Meeting Minutes


7.1 Vaccine Subcommittee Business

The minutes of the meeting of the VSC on the 21 December 2004, extending the indication of MeNZB vaccine to include children from six weeks of age were ratified.

Hide menus
Show menus
0 1 2 4 5 6 7 9 [ /